Trial Profile
A Study to evaluate the effectiveness of denosumab in women with postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Calcium; Colecalciferol
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms DIRP
- 24 Aug 2015 New trial record